$CERS
CERUS CORP Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000119312513423215 Filed on November 01, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$9.232M	$10.54M	$8.252M
YoY Change	-12.31%	27.75%	6.2%
Cost Of Revenue	$4.939M	$6.826M	$4.411M
YoY Change	-3.48%	54.75%	-6.67%
Gross Profit	$4.293M	$3.716M	$3.841M
YoY Change	-20.66%	-3.25%	26.18%
Gross Profit Margin	46.5%	35.25%	46.55%
Selling, General & Admin	$7.430M	$7.728M	$6.219M
YoY Change	9.36%	24.26%	15.59%
% of Gross Profit	173.07%	207.97%	161.91%
Research & Development	$4.618M	$4.363M	$1.903M
YoY Change	113.4%	129.27%	4.91%
% of Gross Profit	107.57%	117.41%	49.54%
Depreciation & Amortization	$340.0K	$130.0K	$180.0K
YoY Change	112.5%	-27.78%	0.0%
% of Gross Profit	7.92%	3.5%	4.69%
Operating Expenses	$12.10M	$12.14M	$8.172M
YoY Change	34.3%	48.57%	12.8%
Operating Profit	-$7.806M	-$8.425M	-$4.331M
YoY Change	116.95%	94.53%	59.11%
Interest Expense	$1.800M	$41.00K	$136.0K
YoY Change	-15.49%	-69.85%
% of Operating Profit
Other Income/Expense, Net	$1.999M	-$12.02M	$926.0K
YoY Change	0.3%	-1397.62%	-81.58%
Pretax Income	-$5.807M	-$20.44M	-$3.405M
YoY Change	261.81%	500.32%	-247.79%
Income Tax	$53.00K	$60.00K	$55.00K
% Of Pretax Income
Net Earnings	-$5.860M	-$20.50M	-$3.460M
YoY Change	241.49%	492.51%	-253.1%
Net Earnings / Revenue	-63.47%	-194.47%	-41.93%
Basic Earnings Per Share	-$0.08	-$0.29	-$0.06
Diluted Earnings Per Share	-$0.10	-$0.29	-$0.08
COMMON SHARES
Basic Shares Outstanding	70.46M shares	69.79M shares	54.88M shares
Diluted Shares Outstanding		69.79M shares	55.38M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.70M	$53.30M	$26.70M
YoY Change	116.1%	99.63%	75.66%
Cash & Equivalents	$29.49M	$24.36M	$26.66M
Short-Term Investments	$28.20M	$29.00M	$0.00
Other Short-Term Assets	$442.0K	$394.0K	$3.200M
YoY Change	-78.31%	-87.69%	190.91%
Inventory	$13.06M	$12.69M	$9.700M
Prepaid Expenses	$848.0K	$1.071M
Receivables	$6.125M	$7.025M	$4.000M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$78.15M	$74.50M	$43.50M
YoY Change	77.64%	71.27%	41.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.189M	$1.848M	$1.800M
YoY Change	28.92%	2.67%	-10.0%
Goodwill	$1.316M	$1.316M
YoY Change	0.0%
Intangibles	$1.344M	$1.395M
YoY Change	-13.07%
Long-Term Investments
YoY Change
Other Assets	$70.00K	$72.00K	$400.0K
YoY Change	18.64%	-82.0%	-42.86%
Total Long-Term Assets	$5.227M	$4.937M	$5.200M
YoY Change	6.18%	-5.06%	-11.86%
TOTAL ASSETS
Total Short-Term Assets	$78.15M	$74.50M	$43.50M
Total Long-Term Assets	$5.227M	$4.937M	$5.200M
Total Assets	$83.38M	$79.44M	$48.70M
YoY Change	70.45%	63.12%	33.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.674M	$4.076M	$5.700M
YoY Change	-21.04%	-28.49%	50.0%
Accrued Expenses	$9.813M	$12.06M	$8.100M
YoY Change	28.8%	48.89%	42.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.400M	$3.600M	$4.900M
YoY Change	-29.17%	-26.53%
Total Short-Term Liabilities	$39.42M	$42.59M	$27.30M
YoY Change	53.92%	56.01%	92.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$3.300M
YoY Change	-100.0%	-100.0%	-32.65%
Other Long-Term Liabilities	$1.073M	$1.120M	$1.100M
YoY Change	-13.54%	1.82%	-15.38%
Total Long-Term Liabilities	$1.073M	$1.120M	$4.400M
YoY Change	-13.54%	-74.55%	-29.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.42M	$42.59M	$27.30M
Total Long-Term Liabilities	$1.073M	$1.120M	$4.400M
Total Liabilities	$40.59M	$43.79M	$31.70M
YoY Change	36.14%	38.15%	55.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$503.2M	-$497.3M
YoY Change	9.42%
Common Stock	$546.0M	$70.00K
YoY Change	974858.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$42.80M	$35.65M	$16.90M
YoY Change
Total Liabilities & Shareholders Equity	$83.38M	$79.44M	$48.70M
YoY Change	70.45%	63.12%	33.06%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$5.860M	-$20.50M	-$3.460M
YoY Change	241.49%	492.51%	-253.1%
Depreciation, Depletion And Amortization	$340.0K	$130.0K	$180.0K
YoY Change	112.5%	-27.78%	0.0%
Cash From Operating Activities	-$6.530M	-$6.090M	-$1.750M
YoY Change	126.74%	248.0%	-50.14%
INVESTING ACTIVITIES
Capital Expenditures	-$220.0K	-$260.0K	-$40.00K
YoY Change	-1200.0%	550.0%	-20.0%
Acquisitions
YoY Change
Other Investing Activities	$650.0K	-$29.17M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$430.0K	-$29.43M	-$40.00K
YoY Change	2050.0%	73475.0%	-136.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.23M	1.670M	1.790M
YoY Change	288.58%	-6.7%	79.0%
NET CHANGE
Cash From Operating Activities	-6.530M	-6.090M	-1.750M
Cash From Investing Activities	430.0K	-29.43M	-40.00K
Cash From Financing Activities	11.23M	1.670M	1.790M
Net Change In Cash	5.130M	-33.85M	-0.0000000009386
YoY Change	17000.0%	3606440755835040000.0%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$6.530M	-$6.090M	-$1.750M
Capital Expenditures	-$220.0K	-$260.0K	-$40.00K
Free Cash Flow	-$6.310M	-$5.830M	-$1.710M
YoY Change	117.59%	240.94%	-50.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26661000
CY2013Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12700000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.43
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33000
CY2013Q3	us-gaap	Secured Debt SecuredDebt	3638000
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10530000	shares
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	42591000
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2013Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2588000
CY2013Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4357000
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	532938000
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4076000
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	22706000
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1120000
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	35646000
CY2013Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	22706000
CY2013Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	3638000
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-497329000
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	111000
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12060000
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
CY2013Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3638000
CY2013Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	22706000
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3740000
CY2013Q3	us-gaap	Liabilities Liabilities	43793000
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	40000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	622000
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	70000
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79439000
CY2013Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	82000
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72000
CY2013Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28971000
CY2013Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1071000
CY2013Q3	us-gaap	Goodwill Goodwill	1316000
CY2013Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	36866000
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	24509000
CY2013Q3	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	306000
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1395000
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7025000
CY2013Q3	us-gaap	Inventory Net InventoryNet	12686000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	12341000
CY2013Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7876000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	50000
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2013Q3	us-gaap	Assets Assets	79439000
CY2012Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4828000
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24355000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1395000
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	394000
CY2013Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4810000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2013Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	36833000
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	12357000
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	36833000
CY2013Q3	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	12686000
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	24492000
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	36866000
CY2013Q3	us-gaap	Assets Current AssetsCurrent	74502000
CY2013Q3	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3638000
CY2013Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	200000
CY2013Q3	cers	Leasehold Improvement Reflected In Other Non Current Liabilities LeaseholdImprovementReflectedInOtherNonCurrentLiabilities	600000
CY2013Q3	cers	Accrued Inventory AccruedInventory	5115000
CY2013Q3	cers	Leasehold Improvement Reflected In Accrued Liabilities LeaseholdImprovementReflectedInAccruedLiabilities	100000
CY2013Q3	cers	Outstanding Liability Related To Leasehold Improvements Current And Non Current OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent	700000
CY2013Q3	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	3	Customer
CY2013Q3	cers	Options And Other Stock Based Awards OptionsAndOtherStockBasedAwards	10600000	shares
CY2013Q3	cers	Performance Based Stock Options Outstanding PerformanceBasedStockOptionsOutstanding	50000	shares
CY2013Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Eight FiniteLivedIntangibleAssetsAmortizationExpenseYearEight	100000
CY2013Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Seven FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven	200000
CY2013Q3	cers	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	33000
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70456000	shares
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25497000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.40
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8504000	shares
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	2896000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25613000
CY2012Q4	us-gaap	Secured Debt SecuredDebt	7724000
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2692000
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2575000
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	478903000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7186000
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5903000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1241000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	19107000
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5903000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-459852000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	77000
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7619000
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7773000
CY2012Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	5903000
CY2012Q4	us-gaap	Liabilities Liabilities	29812000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	471000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	56000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48919000
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	62000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59000
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	638000
CY2012Q4	us-gaap	Goodwill Goodwill	1316000
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	10268000
CY2012Q4	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	304000
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1546000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4444000
CY2012Q4	us-gaap	Inventory Net InventoryNet	10180000
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6629000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1698000
CY2012Q4	us-gaap	Assets Assets	48919000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26696000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1546000
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2038000
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3551000
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	10268000
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	10268000
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	49000
CY2012Q4	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	10180000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	10268000
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	10268000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	43996000
CY2012Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	4857000
CY2012Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	2916000
CY2012Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	29000
CY2012Q4	cers	Accrued Inventory AccruedInventory	2352000
CY2012Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	3	Customer
CY2012Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	20000
	dei	Trading Symbol TradingSymbol	CERS
	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.19
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The restricted stock units vest in three annual installments from the date of grant and are generally issuable at the end of the three-year vesting term
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	189000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66464000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.69
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	177000	shares
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20493000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	440000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-96000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	17663000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47408000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20133000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16301000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	2415000
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and short-term investments are maintained at two major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At September 30, 2013, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px">  </p> <p style="MARGIN-TOP: 0pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Concentrations of credit risk with respect to trade receivables exist. However, in connection with the Company’s revolving line of credit, as discussed in Note 8 in the Notes to Condensed Consolidated Financial Statements, the Company purchased a credit insurance policy that mitigates some of its credit risk, as the policy will pay either the Company or its lender on eligible claims filed on its outstanding receivables. On a regular basis, including at the time of sale, the Company performs credit evaluations of its customers. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company reserves against the accounts receivable on its condensed consolidated balance sheets and records a charge on its condensed consolidated statements of operations. The Company has not historically experienced significant bad debt and accordingly has not maintained an allowance for doubtful accounts.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company had three customers that accounted for more than 10% of the Company’s outstanding trade receivables at both September 30, 2013, and December 31, 2012. These customers cumulatively represented approximately 55% and 59% of the Company’s outstanding trade receivables, at September 30, 2013 and December 31, 2012, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.55	pure
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	111000	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16819000
	us-gaap	Net Income Loss NetIncomeLoss	-37477000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1345000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>Use of Estimates</b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2503000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66464000	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company after December 31, 2002. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. During the year ended December 31, 2012, the Company provided for warranty obligations related to replacement costs for certain of its products that the Company identified were defective or had the potential of being defective. In connection with the warranty obligations provided for in relation to certain of its products during the year ended December 31, 2012, the Company filed a warranty claim against Fresenius, which Fresenius accepted. As a result, the Company recorded a current asset of $1.8 million on its consolidated balance sheet as of December 31, 2012 representing the full amount of the warranty claim against Fresenius as Fresenius was obliged to supply the Company with replacement products or credit notes for those defective or potentially defective products. The Company also wrote-down the value of certain unsalable inventory of $1.7 million related to these products as an offsetting warranty claim against Fresenius as of December 31, 2012. As of September 30, 2013, the Company no longer has a warranty claim against Fresenius and all unsalable inventory related to this incident has been returned to Fresenius. During the three months ended March 31, 2013, the Company identified a separate production defect related to unsold inventory. The Company’s third party manufacturer has taken responsibility for the cost of replacing such damaged goods, therefore, the Company has borne no costs associated with these defects. Prior to these incidents, there have been very few warranty costs incurred. As a result, the Company did not accrue for any potential future warranty costs at September 30, 2013. In addition, the Company believes that the defective products and those that had the potential of being defective identified during the three months ended March 31, 2013 and during the year ended December 31, 2012 are isolated.</p> </div>
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	16803000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-33000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-154000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	14000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	30425000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-37477000
	us-gaap	Interest Paid InterestPaid	242000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-37312000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2581000
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	198000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	6176000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37510000
	us-gaap	Gross Profit GrossProfit	12762000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2341000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	-29162000
	us-gaap	Operating Expenses OperatingExpenses	33255000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22535000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	165000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	34000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4448000
	us-gaap	Interest Expense InterestExpense	279000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3110000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50981000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10569000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2008000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	410000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2415000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29616000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	595000
	cers	Settlements Of Warranty Claims SettlementsOfWarrantyClaims	1272000
	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-16803000
	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
	cers	Payment For Royalty PaymentForRoyalty	2300000
	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	11800000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3238000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15499000
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	9496000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12015000
	us-gaap	Share Based Compensation ShareBasedCompensation	1911000
	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
	cers	Eligible To Receive Royalty Fee EligibleToReceiveRoyaltyFee	0.01	pure
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54130000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11042000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14813000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54130000	shares
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2006000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	26167000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14201000
	us-gaap	Interest Paid InterestPaid	330000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14070000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2146000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-53000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	325000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14201000
	us-gaap	Gross Profit GrossProfit	10668000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Revenue From Grants RevenueFromGrants	91000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13702000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	97000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	9000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-368000
	us-gaap	Net Income Loss NetIncomeLoss	-14201000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1164000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	287000
	us-gaap	Other Noncash Expense OtherNoncashExpense	15000
	us-gaap	Operating Expenses OperatingExpenses	24461000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18871000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	131000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	605000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	17000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2219000
	us-gaap	Interest Expense InterestExpense	410000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1020000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10823000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5439000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1219000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	582000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1911000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	191000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	281000
	cers	Performance Based Stock Options Awards PerformanceBasedStockOptionsAwards	0
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	86000
	cers	Payment For Royalty PaymentForRoyalty	2100000
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	8900000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2012	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.59	pure
CY2012	us-gaap	Inventory Write Down InventoryWriteDown	1700000
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55377000	shares
CY2012Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	502000	shares
CY2012Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8704000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54875000	shares
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8252000
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4333000
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3405000
CY2012Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	187000
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3460000
CY2012Q3	us-gaap	Gross Profit GrossProfit	3841000
CY2012Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4331000
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	926000
CY2012Q3	us-gaap	Dilutive Securities DilutiveSecurities	-873000
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-3460000
CY2012Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4411000
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	8172000
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6219000
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55000
CY2012Q3	us-gaap	Interest Expense InterestExpense	136000
CY2012Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1903000
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	695000
CY2012Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2012Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2012Q3	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	873000
CY2012Q3	cers	Payment For Royalty PaymentForRoyalty	700000
CY2012Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	1400000
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69791000	shares
CY2013Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16651000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69791000	shares
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-33000
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10542000
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20501000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20441000
CY2013Q3	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2013Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	409000
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20534000
CY2013Q3	us-gaap	Gross Profit GrossProfit	3716000
CY2013Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8425000
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12016000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-20501000
CY2013Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6826000
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	12141000
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7728000
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000
CY2013Q3	us-gaap	Interest Expense InterestExpense	41000
CY2013Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4363000
CY2013Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	861000
CY2013Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2013Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2013Q3	cers	Performance Based Stock Options Awards PerformanceBasedStockOptionsAwards	0
CY2013Q3	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-12416000
CY2013Q3	cers	Payment For Royalty PaymentForRoyalty	800000
CY2013Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4200000

Files In Submission

Name	View Source	Status
0001193125-13-423215-index-headers.html	Edgar Link	pending
0001193125-13-423215-index.html	Edgar Link	pending
0001193125-13-423215.txt	Edgar Link	pending
0001193125-13-423215-xbrl.zip	Edgar Link	pending
cers-20130930.xml	Edgar Link	completed
cers-20130930.xsd	Edgar Link	pending
cers-20130930_cal.xml	Edgar Link	unprocessable
cers-20130930_def.xml	Edgar Link	unprocessable
cers-20130930_lab.xml	Edgar Link	unprocessable
cers-20130930_pre.xml	Edgar Link	unprocessable
d586978d10q.htm	Edgar Link	pending
d586978dex101.htm	Edgar Link	pending
d586978dex311.htm	Edgar Link	pending
d586978dex312.htm	Edgar Link	pending
d586978dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
CERUS CORP Stock $cers

2013 Q4 Form 10-Q Financial Statement

#000119312513423215 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS CERUS CORP Stock $cers

2013 Q4 Form 10-Q Financial Statement

#000119312513423215 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
CERUS CORP Stock $cers